Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection

Medical and Pediatric Oncology

Volumn 41, Issue 5, 2003, Pages 436-443

  Ammann, Roland A ^a,b   Hirt, Andreas ^a   Lüthy, Annette Ridolfi ^a   Aebi, Christoph ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bacterial infection; Febrile neutropenia; Myelotoxicity

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; CEFTRIAXONE; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; B CELL LEUKEMIA; BACTERIAL INFECTION; BONE MARROW EXAMINATION; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; DECISION THEORY; EMERGENCY TREATMENT; FEBRILE NEUTROPENIA; FEMALE; FEVER; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; NEUTROPENIA; PATIENT SELECTION; PRE B LYMPHOCYTE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY ANALYSIS; STATISTICAL MODEL; VALIDATION PROCESS; VIRUS INFECTION;

ADOLESCENT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FEVER; HUMANS; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; NEOPLASMS; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SWITZERLAND;

EID: 0141960348     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10320     Document Type: Article

References (20)

1. Hann I, Viscoli C, Paesmans M, et al. A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997;99:580-588.
2. Alexander SW, Walsh TJ, Freifeld AG, et al. Infectious complications in pediatric cancer patients. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins; 2002. pp 1239-1283.
3. Klaassen RJ, Goodmann TR, Pham B, et al. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 2000;18:1012-1019.
4. de Bont ESJM, Vellenga E, Swaanenburg JCJM, et al. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol 1999;107:375-380.
5. Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 2001;19:3415-3421.
6. Bash RO, Katz JA, Cash JV, et al. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia. Cancer 1994;74:189-196.
7. Wacker P, Halperin DS, Wyss M, et al. Early hospital discharge of children with fever and neutropenia: A prospective study. J Pediatr Hematol Oncol 1997;19:208-211.
8. Aquino VM, Herrera L, Sandler ES, et al. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 2000;88:1710-1714.
9. Charnas R, Ridolfi Lüthi A, Ruch W. Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Pediatr Infect Dis J 1997;16:346-353.
10. Pizzo PA, Robichaud KJ, Wesley R, et al. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine (Baltimore) 1982;61:153-165.
11. Lucas KG, Brown AE, Armstrong D, et al. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 1996;77:791-798.
12. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991. 611 p.
13. Breiman L, Friedman JH, Olshen RA, et al. Classification and regression trees. Monterey, CA: Wadsworth and Brooks/Cole; 1984. 358 p.
14. Zhang H, Singer B. Recursive partitioning in the health sciences. New York, Berlin, Heidelberg: Springer; 1999. 225 p.
15. Breiman L. Bagging predictors. Machine Learn 1996;24:123-140.
16. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
17. Blyth C, Still H. Binomial confidence intervals. J Am Stat Assoc 1983;78:108-116.
18. Casella G. Refining binomial confidence intervals. Can J Stat 1986;14:113-129.
19. Neth O, Hann I, Turner MW, et al. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: A prospective study. Lancet 2001;358:614-618.
20. Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000;18:3038-3051.